September 28, 2021 Based on the consensus reached with its restructuring partner, Kiwa Bio-Tech Products Group Corporation (KIWA, or the “Company”) has formally submitted an application to re-activate its account at the OTC Markets, and has paid related fees. The application is currently under the OTC Markets’ review. The Company’s legal counsel also urged the…
On September 13, 2021, the Board of Directors of Kiwa Bio-Tech officially announced that the first phase of the company’s restructuring has been completed. Mr. Wade Li, Chairman and CEO, said that Kiwa has re-appointed JLKZ CPA LLP as the company’s auditor, and VCL LAW LLP as the company’s legal counsel. The company has recently…
Recently, the Board of Directors of Kiwa and the Board of Directors of our Chinese partner “Global Holding Group” held several innumerable restructuring Cooperation meetings in Beijing, China. Since the Global Holding Group has just completed the internal restructuring itself. and China is once again affected by the epidemic and cannot communicate freely among many…